$PGTK
Pacific Green Technologies Inc. Stock $pgtk

$pgtk Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000121390023052925 Filed on June 29, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$1.189M	$779.9K	$7.639M
YoY Change	-41.26%	-92.13%	-50.52%
Cost Of Revenue	$1.218M	$532.0K	$5.833M
YoY Change	-0.88%	-62.52%	28.0%
Gross Profit	-$28.93K	$247.9K	$1.806M
YoY Change	-103.64%	-97.08%	-83.4%
Gross Profit Margin	-2.43%	31.79%	23.65%
Selling, General & Admin	$6.972M	$2.483M	$11.84M
YoY Change	119.31%	-1.18%	-14.64%
% of Gross Profit		1001.45%	655.32%
Research & Development	$32.20K	$0.00	$13.77K
YoY Change	133.79%
% of Gross Profit		0.0%	0.76%
Depreciation & Amortization	$37.12K	$262.7K	$1.071M
YoY Change	-30.73%	-42.21%	409.52%
% of Gross Profit		105.97%	59.32%
Operating Expenses	$7.819M	$2.464M	$11.42M
YoY Change	99.14%	80.77%	-48.35%
Operating Profit	-$7.848M	-$2.216M	-$9.614M
YoY Change	150.64%	-131.12%	-14.38%
Interest Expense	-$2.120M	-$1.567M	-$1.875M
YoY Change	332.91%	80.34%	254.33%
% of Operating Profit
Other Income/Expense, Net	$10.81M		-$1.164M
YoY Change	136439.1%		-344.5%
Pretax Income	$2.963M	-$4.089M	-$11.79M
YoY Change	-194.86%	405.71%	9.69%
Income Tax	$622.2K		-$2.477M
% Of Pretax Income	21.0%
Net Earnings	$3.288M	-$3.592M	-$11.32M
YoY Change	-200.89%	344.26%	5.25%
Net Earnings / Revenue	276.59%	-460.56%	-148.15%
Basic Earnings Per Share	$0.06		-$0.25
Diluted Earnings Per Share	$0.06	-$0.08	-$0.24
COMMON SHARES
Basic Shares Outstanding	49.97M shares	47.28M shares	47.28M shares
Diluted Shares Outstanding	47.65M shares		47.28M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.269M	$1.217M	$1.217M
YoY Change	20.19%	-85.19%	-85.19%
Cash & Equivalents	$8.269M	$1.160M
Short-Term Investments	$0.00	$56.48K	$56.48K
Other Short-Term Assets	$3.993M	$789.6K	$789.6K
YoY Change	200.84%	27.34%	27.34%
Inventory
Prepaid Expenses	$811.5K	$325.8K
Receivables	$1.843M	$1.391M	$1.391M
Other Receivables	$27.36K	$359.5K	$359.5K
Total Short-Term Assets	$11.52M	$3.757M	$3.757M
YoY Change	-1.67%	-84.88%	-84.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$778.1K	$1.200M	$1.200M
YoY Change	-27.44%	2.86%	-37.04%
Goodwill
YoY Change
Intangibles	$6.453M	$6.706M
YoY Change	-6.2%	-5.54%
Long-Term Investments
YoY Change
Other Assets	$741.3K	$18.90M	$18.90M
YoY Change	-93.69%	293.36%	293.36%
Total Long-Term Assets	$8.231M	$26.81M	$26.81M
YoY Change	-59.49%	94.12%	94.12%
TOTAL ASSETS
Total Short-Term Assets	$11.52M	$3.757M	$3.757M
Total Long-Term Assets	$8.231M	$26.81M	$26.81M
Total Assets	$19.75M	$30.57M	$30.57M
YoY Change	-38.35%	-20.95%	-20.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.791M	$692.5K	$692.5K
YoY Change	84.1%	-8.53%	-8.53%
Accrued Expenses	$1.677M	$2.714M	$2.714M
YoY Change	-63.57%	-68.33%	-70.68%
Deferred Revenue	$8.039M	$8.751M
YoY Change		8.07%
Short-Term Debt	$0.00	$2.459M	$2.459M
YoY Change	-100.0%	4371.18%	4371.18%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.79M	$15.54M	$15.54M
YoY Change	-2.79%	-18.56%	-18.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$97.78K	$212.6K	$212.6K
YoY Change	-1.44%	-37.83%	-37.83%
Total Long-Term Liabilities	$97.78K	$212.6K	$212.6K
YoY Change	-1.44%	-37.83%	-37.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.79M	$15.54M	$15.54M
Total Long-Term Liabilities	$97.78K	$212.6K	$212.6K
Total Liabilities	$15.89M	$31.41M	$31.41M
YoY Change	-2.79%	61.75%	5.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$93.66M	-$96.85M
YoY Change	5.49%	13.23%
Common Stock	$49.97K	$372.3K
YoY Change	6.26%	691.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$99.75K
YoY Change		0.0%
Treasury Stock Shares
Shareholders Equity	$4.005M	-$848.1K	-$848.1K
YoY Change
Total Liabilities & Shareholders Equity	$19.75M	$30.57M	$30.57M
YoY Change	-38.35%	-20.95%	-20.95%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	$3.288M	-$3.592M	-$11.32M
YoY Change	-200.89%	344.26%	5.25%
Depreciation, Depletion And Amortization	$37.12K	$262.7K	$1.071M
YoY Change	-30.73%	-42.21%	409.52%
Cash From Operating Activities	-$6.105M	$14.09M	$7.998M
YoY Change	-196.72%	-700.98%	-150.13%
INVESTING ACTIVITIES
Capital Expenditures	$3.215K	$0.00	$1.060K
YoY Change	-64.48%	-100.0%	-99.04%
Acquisitions
YoY Change
Other Investing Activities	$6.270M	-$10.96M	-$42.86M
YoY Change	-189.95%	490.78%	2210.83%
Cash From Investing Activities	$6.266M	-$10.96M	-$42.86M
YoY Change	-189.79%	471.98%	2080.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$16.14M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$6.678M	-6.036M	28.91M
YoY Change			-29156.51%
NET CHANGE
Cash From Operating Activities	-$6.105M	14.09M	7.998M
Cash From Investing Activities	$6.266M	-10.96M	-42.86M
Cash From Financing Activities	$6.678M	-6.036M	28.91M
Net Change In Cash	$7.039M	-2.900M	-5.949M
YoY Change	-493.47%	-31.93%	-65.31%
FREE CASH FLOW
Cash From Operating Activities	-$6.105M	$14.09M	$7.998M
Capital Expenditures	$3.215K	$0.00	$1.060K
Free Cash Flow	-$6.108M	$14.09M	$7.997M
YoY Change	-196.9%	-717.02%	-149.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Security Exchange Name SecurityExchangeName	NONE
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-54756
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	36-4966163
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Suite 10212
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	8 The Green
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Dover
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	DE
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19901
CY2023	dei	City Area Code CityAreaCode	(302)
CY2023	dei	Local Phone Number LocalPhoneNumber	601-4659
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2023	dei	Trading Symbol TradingSymbol	PGTK
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	17373007	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49970724	shares
CY2023	dei	Auditor Firm AuditorFirmId	1337
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON UK LLP
CY2023	dei	Auditor Location AuditorLocation	London, United Kingdom
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1160358	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6286468	usd
CY2023Q1	pgtk	Shortterm Investments And Amounts In Escrow Note3 ShorttermInvestmentsAndAmountsInEscrowNote3	56483	usd
CY2022Q1	pgtk	Shortterm Investments And Amounts In Escrow Note3 ShorttermInvestmentsAndAmountsInEscrowNote3	1932323	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	97640	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	828461	usd
CY2023Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	886663	usd
CY2022Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	4884101	usd
CY2023Q1	pgtk	Other Receivable For Doubtful Account OtherReceivableForDoubtfulAccount	3951	usd
CY2022Q1	pgtk	Other Receivable For Doubtful Account OtherReceivableForDoubtfulAccount	1512	usd
CY2023Q1	pgtk	Other Receivable Net Current OtherReceivableNetCurrent	359461	usd
CY2022Q1	pgtk	Other Receivable Net Current OtherReceivableNetCurrent	10599746	usd
CY2023Q1	pgtk	Accrued Revenue AccruedRevenue	504766	usd
CY2022Q1	pgtk	Accrued Revenue AccruedRevenue	531947	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	325788	usd
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	582063	usd
CY2023Q1	pgtk	Prepaid Manufacturing Costs PrepaidManufacturingCosts	463815	usd
CY2022Q1	pgtk	Prepaid Manufacturing Costs PrepaidManufacturingCosts	38010	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	3757334	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	24854658	usd
CY2023Q1	pgtk	Assets Held For Sale Note4 AssetsHeldForSaleNote4	18569060	usd
CY2023Q1	pgtk	Project Under Development ProjectUnderDevelopment	39970	usd
CY2022Q1	pgtk	Project Under Development ProjectUnderDevelopment	3855792	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	849209	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1166241	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6706484	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7099748	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	350429	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	739091	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	293680	usd
CY2022Q1	us-gaap	Security Deposit SecurityDeposit	949644	usd
CY2023Q1	us-gaap	Assets Assets	30566166	usd
CY2022Q1	us-gaap	Assets Assets	38665174	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3388733	usd
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9594787	usd
CY2023Q1	pgtk	Warranty Provision Current WarrantyProvisionCurrent	580530	usd
CY2022Q1	pgtk	Warranty Provision Current WarrantyProvisionCurrent	865451	usd
CY2023Q1	pgtk	Contract Liabilities Current ContractLiabilitiesCurrent	8751125	usd
CY2022Q1	pgtk	Contract Liabilities Current ContractLiabilitiesCurrent	8143109	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	2459146	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	145437	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	472068	usd
CY2023Q1	pgtk	Due To Related Parties Note15 DueToRelatedPartiesNote15	213020	usd
CY2022Q1	pgtk	Due To Related Parties Note15 DueToRelatedPartiesNote15	4250	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	15537991	usd
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	19079665	usd
CY2023Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	127974	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	84621	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	341972	usd
CY2023Q1	us-gaap	Liabilities Liabilities	15750586	usd
CY2022Q1	us-gaap	Liabilities Liabilities	19421637	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47276886	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47276886	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47026886	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47026886	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	47277	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	47027	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	93107946	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	92429203	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2944086	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2035666	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-96847650	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85530306	usd
CY2023Q1	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	-748341	usd
CY2022Q1	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	8981590	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	56162	shares
CY2022Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	56162	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	99754	usd
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	99754	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-848095	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8881836	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	15663675	usd
CY2022Q1	us-gaap	Minority Interest MinorityInterest	10361701	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14815580	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19243537	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30566166	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38665174	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1164490	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	476277	usd
CY2023	us-gaap	Revenues Revenues	7639165	usd
CY2022	us-gaap	Revenues Revenues	15439199	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	5832725	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	4556840	usd
CY2023	us-gaap	Gross Profit GrossProfit	1806440	usd
CY2022	us-gaap	Gross Profit GrossProfit	10882359	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	507828	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	599520	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2622	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	697126	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-52232	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-36526	usd
CY2023	us-gaap	Depreciation Depreciation	191404	usd
CY2022	us-gaap	Depreciation Depreciation	210292	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-966368	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1005418	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	49438	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4419315	usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	2641639	usd
CY2023	pgtk	Consulting Fees Technical Support And Commissions ConsultingFeesTechnicalSupportAndCommissions	2821347	usd
CY2022	pgtk	Consulting Fees Technical Support And Commissions ConsultingFeesTechnicalSupportAndCommissions	3366903	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	566762	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	485087	usd
CY2023	pgtk	Office And Miscellaneous OfficeAndMiscellaneous	1626921	usd
CY2022	pgtk	Office And Miscellaneous OfficeAndMiscellaneous	1770341	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	1692925	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1803435	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13772	usd
CY2023	pgtk	Salaries And Wage Expenses SalariesAndWageExpenses	3862647	usd
CY2022	pgtk	Salaries And Wage Expenses SalariesAndWageExpenses	4993145	usd
CY2023	pgtk	Other Financial Service Costs OtherFinancialServiceCosts	58666	usd
CY2022	pgtk	Other Financial Service Costs OtherFinancialServiceCosts	232365	usd
CY2023	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	753154	usd
CY2022	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	654563	usd
CY2023	pgtk	Warranty And Related Expenserecovery WarrantyAndRelatedExpenserecovery	-625664	usd
CY2022	pgtk	Warranty And Related Expenserecovery WarrantyAndRelatedExpenserecovery	-731529	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	12435958	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	22111094	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-10629518	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-11228735	usd
CY2023	pgtk	Interest Income On Finance Lease InterestIncomeOnFinanceLease	90436	usd
CY2022	pgtk	Interest Income On Finance Lease InterestIncomeOnFinanceLease	456761	usd
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-255947	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-998979	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	19516	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-11794008	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-10752458	usd
CY2023	pgtk	Preference Coupon Distributions PreferenceCouponDistributions	115240	usd
CY2023	pgtk	Share Of Loss Income Attributablepartners ShareOfLossIncomeAttributablepartners	-470227	usd
CY2023	pgtk	Share Of Loss Income Attributable To Ncijv ShareOfLossIncomeAttributableToNCIJV	-121677	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11317344	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10752458	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	908420	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1142934	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10408924	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9609524	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47281407	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47302746	shares
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18488967	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	77897	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	250	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	24000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	99754	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	10361701	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1142934	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10752458	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19243537	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	191493	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	487500	usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	5301974	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	908420	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11317344	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14815580	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-11794008	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-10752458	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2622	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	697126	usd
CY2023	pgtk	Amortization Of Intangible Assets Cogs AmortizationOfIntangibleAssetsCOGS	877468	usd
CY2022	pgtk	Amortization Of Intangible Assets Cogs AmortizationOfIntangibleAssetsCOGS	877468	usd
CY2023	pgtk	Bad Debt Expense Recovery BadDebtExpenseRecovery	52232	usd
CY2022	pgtk	Bad Debt Expense Recovery BadDebtExpenseRecovery	-36526	usd
CY2023	us-gaap	Depreciation Depreciation	191404	usd
CY2022	us-gaap	Depreciation Depreciation	210292	usd
CY2023	pgtk	Amount Of Fair Value When Estimating The Value Of Stock Options AmountOfFairValueWhenEstimatingTheValueOfStockOptions	191493	usd
CY2022	pgtk	Amount Of Fair Value When Estimating The Value Of Stock Options AmountOfFairValueWhenEstimatingTheValueOfStockOptions	77897	usd
CY2022	pgtk	Financing Interest FinancingInterest	456761	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4419315	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2641639	usd
CY2023	pgtk	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment	49438	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-35881	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	105112	usd
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-255947	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	566762	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	485087	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	24000	usd
CY2023	pgtk	Increase Decrease In Shortterm Investments And Amount Held In Trust IncreaseDecreaseInShorttermInvestmentsAndAmountHeldInTrust	-1875840	usd
CY2022	pgtk	Increase Decrease In Shortterm Investments And Amount Held In Trust IncreaseDecreaseInShorttermInvestmentsAndAmountHeldInTrust	805595	usd
CY2023	pgtk	Accounts Receivable And Other Receivables AccountsReceivableAndOtherReceivables	-3762214	usd
CY2022	pgtk	Accounts Receivable And Other Receivables AccountsReceivableAndOtherReceivables	-9509143	usd
CY2023	pgtk	Increase Decrease In Accrued Revenue IncreaseDecreaseInAccruedRevenue	27181	usd
CY2022	pgtk	Increase Decrease In Accrued Revenue IncreaseDecreaseInAccruedRevenue	1042637	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-251821	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-37110	usd
CY2023	pgtk	Security Deposits Other Advances SecurityDepositsOtherAdvances	160362	usd
CY2023	pgtk	Increase Decrease In Lease Payments IncreaseDecreaseInLeasePayments	689747	usd
CY2022	pgtk	Increase Decrease In Lease Payments IncreaseDecreaseInLeasePayments	524197	usd
CY2023	pgtk	Increase Decrease In Prepaid Manufacturing Costs IncreaseDecreaseInPrepaidManufacturingCosts	-425805	usd
CY2022	pgtk	Increase Decrease In Prepaid Manufacturing Costs IncreaseDecreaseInPrepaidManufacturingCosts	1027455	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5823848	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-19156391	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	17899147	usd
CY2023	pgtk	Increase Decrease In Warranty Accrual IncreaseDecreaseInWarrantyAccrual	-284921	usd
CY2022	pgtk	Increase Decrease In Warranty Accrual IncreaseDecreaseInWarrantyAccrual	-1559656	usd
CY2023	pgtk	Increase Decrease In Contract Liabilities IncreaseDecreaseInContractLiabilities	-608016	usd
CY2022	pgtk	Increase Decrease In Contract Liabilities IncreaseDecreaseInContractLiabilities	3437785	usd
CY2023	us-gaap	Increase Decrease In Due To Other Related Parties Current IncreaseDecreaseInDueToOtherRelatedPartiesCurrent	208770	usd
CY2022	us-gaap	Increase Decrease In Due To Other Related Parties Current IncreaseDecreaseInDueToOtherRelatedPartiesCurrent	-170587	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7998269	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15955899	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1055	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	110496	usd
CY2023	pgtk	Increase Decrease Projects Under Development IncreaseDecreaseProjectsUnderDevelopment	-42858436	usd
CY2022	pgtk	Increase Decrease Projects Under Development IncreaseDecreaseProjectsUnderDevelopment	-1854676	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42859491	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1965172	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	16140340	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	12772052	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	250	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	99754	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28912392	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-99504	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	936100	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	870626	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5012730	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1273738	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17149949	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6286468	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23436417	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.80	pure
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6286468	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	487500	usd
CY2023Q1	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	1160358	usd
CY2022Q1	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	6286468	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	113380	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1273738	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6286468	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Operations and Basis of presentation</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Pacific Green Technologies Inc. (the “Company”) was incorporated in the state of Delaware, USA on March 10, 1994. The Company is in the business of acquiring, developing, and marketing environmental technologies, with a focus on emission control technologies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In connection with preparing consolidated financial statements for each annual and interim reporting period, the Company is required to evaluate whether there are conditions or events, considered in aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued. Substantial doubt exists when conditions and events, considered in aggregate, indicate that it is probable that a company will be unable to meet its obligations as they become due within one year after the date that the consolidated financial statements are issued. This evaluation initially does not take into consideration the potential mitigating effect of management’s plans and actions that have not been fully implemented as of the date that the financial statements are issued. When substantial doubt exists, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both: (1) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued; and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Generally, to be considered probable of being effectively implemented, the plans must have been approved before the date that the financial statements are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Management’s evaluation has concluded that there are no known or currently foreseeable conditions or events that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these consolidated financial statements are issued. These consolidated financial statements have therefore been prepared on the basis that the Company will continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The assessment of the liquidity and going concern requires the Company to make judgments about the existence of conditions or events that raise substantial doubt about the ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. This includes judgments about the Company’s future activities and the timing thereof and estimates of future cash flows. Significant assumptions used in the Company’s forecasted model of liquidity include forecasted sales, costs, and capital expenditures. Changes in the assumptions could have a material impact on the forecasted liquidity and going concern assessment.</p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Estimates</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of these consolidated financial statements in conformity with United States Generally Accepted Accounting Principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of property and equipment and intangible assets, prepaid manufacturing costs, and contract liabilities associated with revenue contracts in progress, contingent consideration on asset acquisition, warranty accruals, going concern, and deferred income tax asset valuation allowances. Our company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by our company may differ materially and adversely from our company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
CY2023	pgtk	Revenue And Interest Income Percentage RevenueAndInterestIncomePercentage	0.054	pure
CY2023	pgtk	Service Agreement ServiceAgreement	P3Y
CY2023Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P17Y
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	56483	usd
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	1932323	usd
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2022Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	3696760	usd
CY2023Q1	us-gaap	Financing Receivable Percent Past Due1 FinancingReceivablePercentPastDue1	0.81	pure
CY2022Q1	us-gaap	Financing Receivable Percent Past Due1 FinancingReceivablePercentPastDue1	0.90	pure
CY2023	pgtk	Warrant Provision WarrantProvision	0.02	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.50	pure
CY2022	us-gaap	Other Expenses OtherExpenses	50553	usd
CY2023	pgtk	Antidilutive Shares Outstanding AntidilutiveSharesOutstanding	275000	shares
CY2022	pgtk	Antidilutive Shares Outstanding AntidilutiveSharesOutstanding	225000	shares
CY2022	pgtk	Proceeds From Customer Refundable Fees ProceedsFromCustomerRefundableFees	1871486	usd
CY2023Q1	pgtk	Reallocated Assets And Liabilities ReallocatedAssetsAndLiabilities	18569060	usd
CY2023Q2	srt	Securities Purchased Under Agreements To Resell Average Yield SecuritiesPurchasedUnderAgreementsToResellAverageYield	1	pure
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	74000000	eur
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	93000000	usd
CY2023Q1	us-gaap	Cash Cash	113380	usd
CY2022Q1	us-gaap	Cash Cash	1081	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4454	usd
CY2023Q1	us-gaap	Other Receivables OtherReceivables	61576	usd
CY2022Q1	us-gaap	Other Receivables OtherReceivables	10574463	usd
CY2023Q1	us-gaap	Real Estate Assets Held For Development And Sale RealEstateAssetsHeldForDevelopmentAndSale	46674258	usd
CY2022Q1	us-gaap	Real Estate Assets Held For Development And Sale RealEstateAssetsHeldForDevelopmentAndSale	3855792	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	495602	usd
CY2022Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	200691	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	2302049	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	638156	usd
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1329515	usd
CY2023Q1	us-gaap	Loans Payable LoansPayable	10312906	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	17771173	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2360024	usd
CY2023Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	18569060	usd
CY2022Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	13302512	usd
CY2023Q1	pgtk	Project Under Development ProjectUnderDevelopment	39970	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	191404	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	210292	usd
CY2023	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	81789	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36351900	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-9188161	usd
CY2023Q1	pgtk	Cumulative Impairment CumulativeImpairment	-20457255	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6706484	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7099748	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7099748	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	487501	usd
CY2023	pgtk	Amortization Of Intangible Asset AmortizationOfIntangibleAsset	-880090	usd
CY2023	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	-675	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6706484	usd
CY2023	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	880090	usd
CY2022	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	1574594	usd
CY2023	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	877467	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	877468	usd
CY2023	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	2623	usd
CY2022	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	697126	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2641639	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	948697	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	948697	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	946220	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	946018	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	946018	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	1970833	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Fair Value Disclosure FiniteLivedIntangibleAssetsFairValueDisclosure	6706483	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	3870224	usd
CY2023	us-gaap	Acquisition Costs AcquisitionCosts	1760000	jpy
CY2023	us-gaap	Acquisition Costs AcquisitionCosts	255947	usd
CY2022Q1	us-gaap	Goodwill Fair Value Disclosure GoodwillFairValueDisclosure	549091	usd
CY2022	pgtk	Fair Value Payment FairValuePayment	23920	usd
CY2021Q1	us-gaap	Cash Cash	681957	usd
CY2021Q1	us-gaap	Cash Cash	494351	eur
CY2021Q1	pgtk	Conditional Payments ConditionalPayments	515622	usd
CY2021Q1	pgtk	Conditional Payments ConditionalPayments	374500	eur
CY2023	us-gaap	Dividends Cash DividendsCash	1	usd
CY2023	pgtk	Net Working Capital NetWorkingCapital	535	usd
CY2023Q1	us-gaap	Deposit Assets DepositAssets	164799	usd
CY2023	pgtk	Incurred And Capitalized Project Under Development IncurredAndCapitalizedProjectUnderDevelopment	46674258	usd
CY2021Q3	us-gaap	Cash Cash	415855	usd
CY2021Q3	us-gaap	Cash Cash	373500	eur
CY2022Q4	us-gaap	Cash Cash	8710145	usd
CY2022Q4	us-gaap	Cash Cash	7126500	eur
CY2023	pgtk	Total Puchase Consideration TotalPuchaseConsideration	7500000	eur
CY2022Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	16000000	usd
CY2022Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	13000000	eur
CY2022Q1	pgtk	Equity Voting Rights Percentage EquityVotingRightsPercentage	0.65	pure
CY2022Q1	us-gaap	Minority Interest Description MinorityInterestDescription	The Company received $7.0 million (£5.35 million) on April 1, 2022, $1.9 million (£1.43 million) in May 2022, $0.99 million (£0.79 million) in June 2022, $1.0 million (£0.83 million) in July 2022, $1.0 million (£0.82 million) in August 2022 and $4.3 million (£3.57 million) in September 2022.
CY2020Q4	pgtk	Interest In Joint Venture InterestInJointVenture	0.70	pure
CY2023Q1	us-gaap	Other Minority Interests OtherMinorityInterests	16140339	usd
CY2022Q1	us-gaap	Other Minority Interests OtherMinorityInterests	10361701	usd
CY2023	pgtk	Net Income Attributable To Noncontrolling Interest Bess NetIncomeAttributableToNoncontrollingInterestBESS	-354987	usd
CY2023	pgtk	Net Income Attributable To Noncontrolling Interest Jv NetIncomeAttributableToNoncontrollingInterestJV	-121677	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	15663675	usd
CY2022Q1	us-gaap	Minority Interest MinorityInterest	10361701	usd
CY2023	pgtk	Revenue From Related Party RevenueFromRelatedParty	7639165	usd
CY2022	pgtk	Revenue From Related Party RevenueFromRelatedParty	15439199	usd
CY2023	us-gaap	Amount Recognized In Net Periodic Benefit Cost And Other Comprehensive Income Loss Before Tax AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax	2546220	usd
CY2022	us-gaap	Amount Recognized In Net Periodic Benefit Cost And Other Comprehensive Income Loss Before Tax AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax	485019	usd
CY2023Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	460850	usd
CY2022Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	478217	usd
CY2023	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	877468	usd
CY2022	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	877468	usd
CY2023	us-gaap	Payments For Leasing Costs Commissions And Tenant Improvements PaymentsForLeasingCostsCommissionsAndTenantImprovements	232157	usd
CY2022	us-gaap	Payments For Leasing Costs Commissions And Tenant Improvements PaymentsForLeasingCostsCommissionsAndTenantImprovements	664875	usd
CY2023	pgtk	Service Revenue ServiceRevenue	5832725	usd
CY2022	pgtk	Service Revenue ServiceRevenue	4556840	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8751125	usd
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8143109	usd
CY2023Q1	pgtk	Total Contract Liability TotalContractLiability	59335	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	692526	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	757102	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2349083	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8567795	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	127973	usd
CY2022Q1	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	55003	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	219151	usd
CY2022Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	214887	usd
CY2023Q1	pgtk	Short Term Accounts Payable And Accrued Liabilities ShortTermAccountsPayableAndAccruedLiabilities	3388733	usd
CY2022Q1	pgtk	Short Term Accounts Payable And Accrued Liabilities ShortTermAccountsPayableAndAccruedLiabilities	9594787	usd
CY2023Q1	pgtk	Account Payable And Accrued Liabilities Current AccountPayableAndAccruedLiabilitiesCurrent	3388733	usd
CY2022Q1	pgtk	Account Payable And Accrued Liabilities Current AccountPayableAndAccruedLiabilitiesCurrent	9594787	usd
CY2022Q2	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	28250000	eur
CY2022Q2	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	34900000	usd
CY2022Q2	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.045	pure
CY2022Q2	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.045	pure
CY2022Q2	pgtk	Bank Base Rate BankBaseRate	0.20	pure
CY2022Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.07173	pure
CY2022Q2	us-gaap	Line Of Credit LineOfCredit	1190000	usd
CY2022Q2	us-gaap	Line Of Credit LineOfCredit	1470000	eur
CY2023Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	22338	usd
CY2023Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	18060	eur
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual Percent Past Due FinancingReceivableExcludingAccruedInterestNonaccrualPercentPastDue	0.22	pure
CY2023	srt	Interest Bearing Liabilities Average Rate Paid InterestBearingLiabilitiesAverageRatePaid	0.20	pure
CY2023Q1	us-gaap	Other Loans Payable OtherLoansPayable	6000000	usd
CY2023Q1	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	17771173	usd
CY2023Q1	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	14367510	eur
CY2023Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	5509	usd
CY2023Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	4454	eur
CY2023Q1	us-gaap	Loans Payable To Bank LoansPayableToBank	1667484	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	791662	usd
CY2023	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	2459146	usd
CY2023Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current Other AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther	28100000	usd
CY2023	pgtk	Warranty And Related Expenserecovery WarrantyAndRelatedExpenserecovery	-625664	usd
CY2022	pgtk	Warranty And Related Expenserecovery WarrantyAndRelatedExpenserecovery	-731529	usd
CY2022Q1	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.02	pure
CY2023Q1	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.02	pure
CY2023	pgtk	Warrant Balance Beginning Of Period WarrantBalanceBeginningOfPeriod	865451	usd
CY2022	pgtk	Warrant Balance Beginning Of Period WarrantBalanceBeginningOfPeriod	2425107	usd
CY2023	pgtk	Warranty Expense WarrantyExpense	-625664	usd
CY2022	pgtk	Warranty Expense WarrantyExpense	-731529	usd
CY2023	pgtk	Expensesrecoveries Costs ExpensesrecoveriesCosts	340743	usd
CY2022	pgtk	Expensesrecoveries Costs ExpensesrecoveriesCosts	-828127	usd
CY2023	pgtk	Warrant Balance End Of Period WarrantBalanceEndOfPeriod	580530	usd
CY2022	pgtk	Warrant Balance End Of Period WarrantBalanceEndOfPeriod	865451	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	213020	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	4250	usd
CY2023	pgtk	Consulting Fees ConsultingFees	139848	usd
CY2022	pgtk	Consulting Fees ConsultingFees	260479	usd
CY2023Q1	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	On February 6, 2023, the Company issued 250,000 shares of common stock with an aggregate value of $162,500 as part of the consideration for intellectual property transferred from McClelland Management Inc. to the Company under the terms of an IP transfer deed dated January 4, 2023. A further 250,000 shares will be issued in January 2024 and 250,000 shares in January 2025.
CY2023Q1	us-gaap	Common Stock Other Value Outstanding CommonStockOtherValueOutstanding	162500	usd
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	500000	shares
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	325000	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	25000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.01
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	250	usd
CY2021Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	25000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11321	shares
CY2021Q3	pgtk	Fair Value Compensation Per Share FairValueCompensationPerShare	2.12
CY2021Q3	us-gaap	Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued	24000	usd
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	56162	shares
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	99754	usd
CY2021Q1	pgtk	Share Based Compensation Arrangement By Share Based Payment Option Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentOptionOutstandingNumber	3302500	shares
CY2021Q1	pgtk	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice	1.52
CY2022	pgtk	Weighted Average Remaining Contractual Lifeyears Beginning Balance WeightedAverageRemainingContractualLifeyearsBeginningBalance	P0Y8M19D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2300425	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	125000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.14
CY2022	pgtk	Number Of Options Exercised NumberOfOptionsExercised	25000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.01
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	2865000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.7
CY2022Q1	pgtk	Share Based Compensation Arrangement By Share Based Payment Option Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentOptionOutstandingNumber	537500	shares
CY2022Q1	pgtk	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice	0.56
CY2022	pgtk	Weighted Average Remaining Contractual Lifeyears Ending Balance WeightedAverageRemainingContractualLifeyearsEndingBalance	P1Y5M4D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	170125	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	285000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.66
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	337500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.18
CY2023Q1	pgtk	Share Based Compensation Arrangement By Share Based Payment Option Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentOptionOutstandingNumber	485000	shares
CY2023Q1	pgtk	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice	0.89
CY2023	pgtk	Weighted Average Remaining Contractual Lifeyears Ending Balance WeightedAverageRemainingContractualLifeyearsEndingBalance	P1Y7M28D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	103800	usd
CY2023Q1	pgtk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Numbers ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumbers	485000	shares
CY2023Q1	pgtk	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price Vestedand Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePriceVestedandExercisable	0.89
CY2023Q1	pgtk	Weighted Average Remaining Contractual Lifeyears Balance WeightedAverageRemainingContractualLifeyearsBalance	P1Y7M28D
CY2022	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.01
CY2021Q3	us-gaap	Stock Issued During Period Shares Employee Stock Ownership Plan StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan	25000	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.01
CY2021Q3	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	250	usd
CY2021Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	25000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.1
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	25000	shares
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.25	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0444	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.019	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y1M13D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.18	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.29	pure
CY2023	pgtk	Fair Value Of Stock Options Granteded FairValueOfStockOptionsGranteded	191493	usd
CY2022	pgtk	Fair Value Of Stock Options Granteded FairValueOfStockOptionsGranteded	77897	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	16624	usd
CY2023	pgtk	Consultancy Fees ConsultancyFees	174868	usd
CY2023Q1	us-gaap	Property Plant And Equipment Owned Net PropertyPlantAndEquipmentOwnedNet	849209	usd
CY2023Q1	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	6706484	usd
CY2023Q1	pgtk	Right Of Use Asset RightOfUseAsset	350429	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets	7906122	usd
CY2023	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	7639166	usd
CY2023Q1	us-gaap	Customer Funds CustomerFunds	5831978	usd
CY2023Q1	us-gaap	Customers Liability For Acceptances Gross CustomersLiabilityForAcceptancesGross	1807187	usd
CY2023	pgtk	Revenue Not From Contract With Customers RevenueNotFromContractWithCustomers	0.24	pure
CY2022Q1	us-gaap	Property Plant And Equipment Owned Net PropertyPlantAndEquipmentOwnedNet	1166241	usd
CY2022Q1	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	7099748	usd
CY2022Q1	pgtk	Right Of Use Asset RightOfUseAsset	739091	usd
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets	9005080	usd
CY2022	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	15439199	usd
CY2022Q1	us-gaap	Customer Funds CustomerFunds	4556840	usd
CY2022Q1	us-gaap	Customers Liability For Acceptances Gross CustomersLiabilityForAcceptancesGross	10882359	usd
CY2022	pgtk	Revenue Not From Contract With Customers RevenueNotFromContractWithCustomers	0.70	pure
CY2022Q2	us-gaap	Area Of Land AreaOfLand	3.87	acre
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	386337	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	281608	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	233690	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	233690	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	233690	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2148411	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3517426	usd
CY2023Q1	pgtk	Imputed Interest ImputedInterest	1016048	usd
CY2023Q1	pgtk	Operating Lease Obligations OperatingLeaseObligations	2501379	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2360024	usd
CY2023	pgtk	Fund The Venture Proportionately Percentage FundTheVentureProportionatelyPercentage	0.501	pure
CY2023	pgtk	Fund The Venture Proportionately By Suppiler Percentage FundTheVentureProportionatelyBySuppilerPercentage	0.499	pure
CY2023	pgtk	Payments To Acquire Interest In Joint Venture Percentage PaymentsToAcquireInterestInJointVenturePercentage	0.70	pure
CY2023	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	627980	usd
CY2023	pgtk	Shareholders Agreement Amount ShareholdersAgreementAmount	16000000	usd
CY2023	pgtk	Shareholders Agreement Amount ShareholdersAgreementAmount	13000000	eur
CY2023	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	34900000	usd
CY2023	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	28250000	eur
CY2023	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-11794008	usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-10752458	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-11794008	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-10752458	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2476742	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2258016	usd
CY2023	pgtk	Income Tax Reconciliation Permanent Differences And Other IncomeTaxReconciliationPermanentDifferencesAndOther	-361802	usd
CY2022	pgtk	Income Tax Reconciliation Permanent Differences And Other IncomeTaxReconciliationPermanentDifferencesAndOther	545959	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-336980	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	17390	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3175524	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1694667	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.50	pure
CY2023Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	7873396	usd
CY2022Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	4883996	usd
CY2023Q1	pgtk	Tax Basis Of Intangibles And Depreciable Assets In Excess Of Book Value TaxBasisOfIntangiblesAndDepreciableAssetsInExcessOfBookValue	256410	usd
CY2022Q1	pgtk	Tax Basis Of Intangibles And Depreciable Assets In Excess Of Book Value TaxBasisOfIntangiblesAndDepreciableAssetsInExcessOfBookValue	257948	usd
CY2022Q1	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	143127	usd
CY2023Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	381390	usd
CY2022Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	339931	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7998376	usd
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4822852	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7998376	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4822852	usd
CY2017Q4	pgtk	Nol Carryforwards Percentage NOLCarryforwardsPercentage	0.80	pure
CY2023	pgtk	Taxable Income Limitation Period TaxableIncomeLimitationPeriod	P20Y
CY2023	pgtk	Taxable Income Limitation Percentage TaxableIncomeLimitationPercentage	0.80	pure
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	35637000	usd
CY2023Q1	pgtk	Deferred Tax Assets Estimated Tax Losses For Year1 DeferredTaxAssetsEstimatedTaxLossesForYear1	2033000	usd
CY2023Q1	pgtk	Deferred Tax Assets Estimated Tax Losses For Year2 DeferredTaxAssetsEstimatedTaxLossesForYear2	897000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	32707000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	35637000	usd
CY2023	us-gaap	Loss Contingency Settlement Agreement Terms LossContingencySettlementAgreementTerms	The buyer paid an advance of £20m upon signing of the Agreement, of which £7.1m was received by Pacific Green (before fees), the balance being received by the Company’s equity partner. On June 26, 2023 the transaction was formally completed and the buyer paid a further £9.9m, of which £4.2m was received by Pacific Green (before fees), the balance being received by the Company’s equity partner.
CY2023	dei	Entity Registrant Name EntityRegistrantName	Pacific Green Technologies Inc.
CY2022Q1	pgtk	Assets Held For Sale Note4 AssetsHeldForSaleNote4		usd
CY2022Q1	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2022Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent		usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill		usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2022	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2022	pgtk	Preference Coupon Distributions PreferenceCouponDistributions		usd
CY2022	pgtk	Share Of Loss Income Attributablepartners ShareOfLossIncomeAttributablepartners		usd
CY2022	pgtk	Share Of Loss Income Attributable To Ncijv ShareOfLossIncomeAttributableToNCIJV		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2023	pgtk	Financing Interest FinancingInterest		usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022	pgtk	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment		usd
CY2023	pgtk	Interest Accretion On Finance Lease InterestAccretionOnFinanceLease		usd
CY2022	pgtk	Interest Accretion On Finance Lease InterestAccretionOnFinanceLease		usd
CY2022	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022	pgtk	Security Deposits Other Advances SecurityDepositsOtherAdvances		usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue		usd
CY2023Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit		usd
CY2023	us-gaap	Other Expenses OtherExpenses		usd
CY2023	pgtk	Proceeds From Customer Refundable Fees ProceedsFromCustomerRefundableFees		usd
CY2022Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent		usd
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization		usd
CY2022Q1	us-gaap	Loans Payable LoansPayable		usd
CY2022Q1	us-gaap	Long Term Debt LongTermDebt		usd
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent		usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
CY2022	pgtk	Net Income Attributable To Noncontrolling Interest Bess NetIncomeAttributableToNoncontrollingInterestBESS		usd
CY2022	pgtk	Net Income Attributable To Noncontrolling Interest Jv NetIncomeAttributableToNoncontrollingInterestJV		usd
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q1	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure		usd
CY2023Q1	pgtk	Long Term Accrued Liabilities LongTermAccruedLiabilities		usd
CY2022Q1	pgtk	Long Term Accrued Liabilities LongTermAccruedLiabilities		usd
CY2022Q1	us-gaap	Loans Payable To Bank LoansPayableToBank		usd
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2022	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable		usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2022	pgtk	Weighted Average Remaining Contractual Lifeyears Exercised WeightedAverageRemainingContractualLifeyearsExercised
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022	pgtk	Weighted Average Remaining Contractual Lifeyears Forfeited WeightedAverageRemainingContractualLifeyearsForfeited
CY2022	pgtk	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited		usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2023	pgtk	Weighted Average Remaining Contractual Lifeyears Forfeited WeightedAverageRemainingContractualLifeyearsForfeited
CY2023	pgtk	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	48500	shares
CY2023	pgtk	Income Tax Provision IncomeTaxProvision		usd
CY2022	pgtk	Income Tax Provision IncomeTaxProvision		usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	pgtk	Income Tax Provision IncomeTaxProvision		usd
CY2022	pgtk	Income Tax Provision IncomeTaxProvision		usd
CY2023Q1	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards		usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001553404

Files In Submission

Name	View Source	Status
0001213900-23-052925-index-headers.html	Edgar Link	pending
0001213900-23-052925-index.html	Edgar Link	pending
0001213900-23-052925.txt	Edgar Link	pending
0001213900-23-052925-xbrl.zip	Edgar Link	pending
f10k2023ex31-1_pacificgreen.htm	Edgar Link	pending
f10k2023ex31-2_pacificgreen.htm	Edgar Link	pending
f10k2023ex32-1_pacificgreen.htm	Edgar Link	pending
f10k2023ex32-2_pacificgreen.htm	Edgar Link	pending
f10k2023_pacificgreen.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pgtk-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pgtk-20230331_def.xml	Edgar Link	unprocessable
pgtk-20230331_lab.xml	Edgar Link	unprocessable
f10k2023_pacificgreen_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pgtk-20230331_cal.xml	Edgar Link	unprocessable
pgtk-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PGTK
Pacific Green Technologies Inc. Stock $pgtk

2023 Q2 Form 10-K Financial Statement

#000121390023052925 Filed on June 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGTK Pacific Green Technologies Inc. Stock $pgtk

2023 Q2 Form 10-K Financial Statement

#000121390023052925 Filed on June 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGTK
Pacific Green Technologies Inc. Stock $pgtk